| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| GRFSGrifols, S.A. | 2.31B | 8.93 | 38.83 | 9.41% | 4.96% | 4.94% | 23.02% | 1.17 |
| OGNOrganon & Co. | 2.26B | 8.70 | 2.61 | 2.24% | 7.95% | 55.3% | 26% | 19.14 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 9.78B | 7.78B | 6.53B | 6.3B | 6.17B | 6.26B | 6.4B |
| Revenue Growth % | - | -0.2% | -0.16% | -0.03% | -0.02% | 0.01% | 0.02% |
| Cost of Goods Sold | 4.69B | 2.27B | 2.12B | 2.38B | 2.29B | 2.52B | 2.69B |
| COGS % of Revenue | 0.48% | 0.29% | 0.32% | 0.38% | 0.37% | 0.4% | 0.42% |
| Gross Profit | 5.08B | 5.5B | 4.41B | 3.92B | 3.88B | 3.75B | 3.71B |
| Gross Margin % | 0.52% | 0.71% | 0.68% | 0.62% | 0.63% | 0.6% | 0.58% |
| Gross Profit Growth % | - | 0.08% | -0.2% | -0.11% | -0.01% | -0.03% | -0.01% |
| Operating Expenses | 2.38B | 1.66B | 1.57B | 2.01B | 2.17B | 2.42B | 2.23B |
| OpEx % of Revenue | 0.24% | 0.21% | 0.24% | 0.32% | 0.35% | 0.39% | 0.35% |
| Selling, General & Admin | 2.01B | 1.44B | 1.36B | 1.67B | 1.7B | 1.89B | 1.76B |
| SG&A % of Revenue | 0.21% | 0.19% | 0.21% | 0.26% | 0.28% | 0.3% | 0.27% |
| Research & Development | 365M | 220M | 210M | 443M | 471M | 528M | 469M |
| R&D % of Revenue | 0.04% | 0.03% | 0.03% | 0.07% | 0.08% | 0.08% | 0.07% |
| Other Operating Expenses | 0 | 0 | 0 | -104M | 0 | 0 | 0 |
| Operating Income | 2.71B | 3.85B | 2.85B | 1.92B | 1.71B | 1.33B | 1.49B |
| Operating Margin % | 0.28% | 0.49% | 0.44% | 0.3% | 0.28% | 0.21% | 0.23% |
| Operating Income Growth % | - | 0.42% | -0.26% | -0.33% | -0.11% | -0.22% | 0.12% |
| EBITDA | 4.38B | 4.2B | 2.99B | 2.11B | 1.92B | 1.56B | 1.76B |
| EBITDA Margin % | 0.45% | 0.54% | 0.46% | 0.33% | 0.31% | 0.25% | 0.28% |
| EBITDA Growth % | - | -0.04% | -0.29% | -0.29% | -0.09% | -0.18% | 0.13% |
| D&A (Non-Cash Add-back) | 1.67B | 354M | 142M | 195M | 212M | 236M | 277M |
| EBIT | 2.71B | 3.56B | 2.85B | 1.79B | 1.54B | 1.2B | 1.33B |
| Net Interest Income | 0 | 13M | -6M | -258M | -422M | -527M | -520M |
| Interest Income | 0 | 19M | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 6M | 6M | 258M | 422M | 527M | 520M |
| Other Income/Expense | 23M | -144M | -95M | -386M | -583M | -654M | -679M |
| Pretax Income | 2.73B | 3.7B | 2.75B | 1.53B | 1.12B | 673M | 807M |
| Pretax Margin % | 0.28% | 0.48% | 0.42% | 0.24% | 0.18% | 0.11% | 0.13% |
| Income Tax | 576M | 390M | 496M | 178M | 205M | -350M | -57M |
| Effective Tax Rate % | 0.79% | 0.87% | 0.78% | 0.88% | 0.82% | 1.52% | 1.07% |
| Net Income | 2.15B | 3.22B | 2.16B | 1.35B | 917M | 1.02B | 864M |
| Net Margin % | 0.22% | 0.41% | 0.33% | 0.21% | 0.15% | 0.16% | 0.13% |
| Net Income Growth % | - | 0.49% | -0.33% | -0.37% | -0.32% | 0.12% | -0.16% |
| Net Income (Continuing) | 2.15B | 3.31B | 2.26B | 1.35B | 917M | 1.02B | 864M |
| Discontinued Operations | 0 | 0 | -96M | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 8.51 | 12.71 | 8.52 | 5.33 | 3.59 | 3.99 | 3.33 |
| EPS Growth % | - | 0.49% | -0.33% | -0.37% | -0.33% | 0.11% | -0.17% |
| EPS (Basic) | 8.51 | 12.71 | 8.52 | 5.33 | 3.61 | 4.01 | 3.36 |
| Diluted Shares Outstanding | 253.13M | 253.13M | 253.52M | 253.55M | 255.17M | 256.27M | 259.15M |
| Basic Shares Outstanding | 253.13M | 253.13M | 253.52M | 253.55M | 254.08M | 255.24M | 257.05M |
| Dividend Payout Ratio | - | - | - | 0.11% | 0.32% | 0.29% | 0.34% |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 3.71B | 3.96B | 3.57B | 3.76B | 3.93B | 4.51B | 4.35B |
| Cash & Short-Term Investments | 244M | 319M | 12M | 737M | 706M | 693M | 675M |
| Cash Only | 244M | 319M | 12M | 737M | 706M | 693M | 675M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.59B | 1.57B | 1.41B | 1.51B | 1.61B | 1.86B | 1.49B |
| Days Sales Outstanding | 59.47 | 73.83 | 78.51 | 87.54 | 94.94 | 108.22 | 84.99 |
| Inventory | 994M | 1.07B | 913M | 915M | 1B | 1.31B | 1.32B |
| Days Inventory Outstanding | 77.31 | 171.91 | 157.27 | 140.21 | 159.59 | 190.84 | 179.38 |
| Other Current Assets | 883M | 992M | 1.24B | 596M | 616M | 643M | 861M |
| Total Non-Current Assets | 6.78B | 6.59B | 6.54B | 6.92B | 7.02B | 7.55B | 8.75B |
| Property, Plant & Equipment | 651M | 762M | 1.01B | 1.2B | 1.23B | 1.36B | 1.32B |
| Fixed Asset Turnover | 15.02x | 10.21x | 6.44x | 5.24x | 5.01x | 4.62x | 4.83x |
| Goodwill | 4.6B | 4.6B | 4.6B | 4.6B | 4.6B | 4.6B | 4.68B |
| Intangible Assets | 812M | 569M | 503M | 651M | 649M | 533M | 1.41B |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 27M |
| Other Non-Current Assets | 714M | 659M | 421M | 464M | 272M | 250M | 361M |
| Total Assets | 10.49B | 10.55B | 10.11B | 10.68B | 10.96B | 12.06B | 13.1B |
| Asset Turnover | 0.93x | 0.74x | 0.65x | 0.59x | 0.56x | 0.52x | 0.49x |
| Asset Growth % | - | 0.01% | -0.04% | 0.06% | 0.03% | 0.1% | 0.09% |
| Total Current Liabilities | 1.54B | 1.34B | 2.67B | 2.6B | 2.51B | 2.92B | 2.72B |
| Accounts Payable | 289M | 258M | 259M | 1.38B | 1.13B | 1.31B | 1.15B |
| Days Payables Outstanding | 22.48 | 41.41 | 44.61 | 211.77 | 180.11 | 190.7 | 156.56 |
| Short-Term Debt | 115M | 48M | 8M | 55M | 57M | 55M | 64M |
| Deferred Revenue (Current) | 1000K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 6M | 793M | 2.12B | 975M | 1.14B | 1.34B | 1.37B |
| Current Ratio | 2.40x | 2.95x | 1.33x | 1.45x | 1.56x | 1.54x | 1.60x |
| Quick Ratio | 1.76x | 2.15x | 0.99x | 1.10x | 1.17x | 1.09x | 1.11x |
| Cash Conversion Cycle | 114.3 | 204.32 | 191.16 | 15.98 | 74.42 | 108.37 | 107.81 |
| Total Non-Current Liabilities | 2.6B | 2.17B | 1.95B | 9.59B | 9.34B | 9.21B | 9.91B |
| Long-Term Debt | 34M | 70M | 0 | 9.13B | 8.9B | 8.75B | 8.86B |
| Capital Lease Obligations | 0 | 68M | 23M | 184M | 150M | 125M | 112M |
| Deferred Tax Liabilities | 149M | 139M | 128M | 4M | 19M | 47M | 74M |
| Other Non-Current Liabilities | 2.57B | 1.9B | 1.8B | 279M | 261M | 287M | 865M |
| Total Liabilities | 4.15B | 3.51B | 4.62B | 12.19B | 11.85B | 12.13B | 12.63B |
| Total Debt | 149M | 186M | 31M | 9.36B | 9.11B | 8.93B | 9.04B |
| Net Debt | -95M | -133M | 19M | 8.63B | 8.41B | 8.24B | 8.36B |
| Debt / Equity | 0.02x | 0.03x | 0.01x | - | - | - | 19.14x |
| Debt / EBITDA | 0.03x | 0.04x | 0.01x | 4.44x | 4.75x | 5.71x | 5.13x |
| Net Debt / EBITDA | -0.02x | -0.03x | 0.01x | 4.09x | 4.38x | 5.27x | 4.74x |
| Interest Coverage | - | 641.17x | 474.50x | 7.42x | 4.04x | 2.52x | 2.86x |
| Total Equity | 6.35B | 7.04B | 5.49B | -1.51B | -892M | -70M | 472M |
| Equity Growth % | - | 0.11% | -0.22% | -1.27% | 0.41% | 0.92% | 7.74% |
| Book Value per Share | 25.08 | 27.79 | 21.64 | -5.95 | -3.50 | -0.27 | 1.82 |
| Total Shareholders' Equity | 6.35B | 7.04B | 5.49B | -1.51B | -892M | -70M | 472M |
| Common Stock | 7.26B | 7.95B | 6.11B | 3M | 3M | 3M | 3M |
| Retained Earnings | 0 | 0 | 0 | -998M | -331M | 443M | 1.01B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -908M | -914M | -622M | -513M | -564M | -541M | -649M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | 3.69B | 2.77B | 2.19B | 2.46B | 858M | 799M | 939M |
| Operating CF Margin % | 0.38% | 0.36% | 0.33% | 0.39% | 0.14% | 0.13% | 0.15% |
| Operating CF Growth % | - | -0.25% | -0.21% | 0.12% | -0.65% | -0.07% | 0.18% |
| Net Income | 2.15B | 3.31B | 2.26B | 1.35B | 917M | 1.02B | 864M |
| Depreciation & Amortization | 1.67B | 333M | 142M | 195M | 212M | 236M | 277M |
| Stock-Based Compensation | 56M | 41M | 40M | 59M | 75M | 101M | 105M |
| Deferred Taxes | 37M | 12M | -32M | -288M | -18M | -485M | -160M |
| Other Non-Cash Items | -58M | -253M | -22M | 439M | 124M | 79M | 131M |
| Working Capital Changes | -174M | -672M | -197M | 702M | -452M | -155M | -278M |
| Change in Receivables | 250M | 200M | 159M | -277M | -123M | -212M | 383M |
| Change in Inventory | 44M | -91M | -29M | -138M | -220M | -230M | -131M |
| Change in Payables | 20M | -35M | 27M | 663M | -237M | 163M | -157M |
| Cash from Investing | -69M | -102M | -258M | -481M | -420M | -260M | -513M |
| Capital Expenditures | -101M | -92M | -278M | -488M | -427M | -259M | -351M |
| CapEx % of Revenue | 0.01% | 0.01% | 0.04% | 0.08% | 0.07% | 0.04% | 0.05% |
| Acquisitions | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 32M | -17M | 15M | 192M | 131M | 1M | 4M |
| Cash from Financing | -4.16B | -2.62B | -2.17B | -1.33B | -433M | -569M | -368M |
| Debt Issued (Net) | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | -145M | -290M | -294M | -297M |
| Share Repurchases | - | - | - | - | - | - | - |
| Other Financing | -4.22B | -2.62B | -3.69B | -9.03B | -24M | 0 | -38M |
| Net Change in Cash | - | - | - | - | - | - | - |
| Free Cash Flow | 3.59B | 2.67B | 1.91B | 1.97B | 431M | 538M | 588M |
| FCF Margin % | 0.37% | 0.34% | 0.29% | 0.31% | 0.07% | 0.09% | 0.09% |
| FCF Growth % | - | -0.25% | -0.29% | 0.03% | -0.78% | 0.25% | 0.09% |
| FCF per Share | 14.17 | 10.57 | 7.53 | 7.77 | 1.69 | 2.10 | 2.27 |
| FCF Conversion (FCF/Net Income) | 1.71x | 0.86x | 1.01x | 1.82x | 0.94x | 0.78x | 1.09x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 495M | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 33.92% | 48.09% | 34.5% | 67.92% | - | - | 429.85% |
| Return on Invested Capital (ROIC) | 32.46% | 43.87% | 34.42% | 22.75% | 17.48% | 12.69% | 13.11% |
| Gross Margin | 52% | 70.76% | 67.56% | 62.21% | 62.84% | 59.84% | 58.02% |
| Net Margin | 22.02% | 41.38% | 33.07% | 21.43% | 14.85% | 16.33% | 13.49% |
| Debt / Equity | 0.02x | 0.03x | 0.01x | - | - | - | 19.14x |
| Interest Coverage | - | 641.17x | 474.50x | 7.42x | 4.04x | 2.52x | 2.86x |
| FCF Conversion | 1.71x | 0.86x | 1.01x | 1.82x | 0.94x | 0.78x | 1.09x |
| Revenue Growth | - | -20.46% | -16.01% | -3.49% | -2.06% | 1.44% | 2.24% |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Europe And Canada | - | - | - | 1.76B |
| Europe And Canada Growth | - | - | - | - |
| UNITED STATES | - | - | 1.48B | 1.57B |
| UNITED STATES Growth | - | - | - | 6.36% |
| Asia Pacific and Japan | 1.17B | 1.14B | 1.13B | 1.05B |
| Asia Pacific and Japan Growth | - | -2.56% | -1.22% | -7.00% |
| Latin America, Middle East, Russia And Africa | - | - | - | 1.03B |
| Latin America, Middle East, Russia And Africa Growth | - | - | - | - |
| CHINA | 933M | 917M | 864M | 847M |
| CHINA Growth | - | -1.71% | -5.78% | -1.97% |
| Other Countries | 233M | 151M | 154M | 137M |
| Other Countries Growth | - | -35.19% | 1.99% | -11.04% |
| Europe and Canada | 1.74B | 1.63B | 1.67B | - |
| Europe and Canada Growth | - | -6.32% | 2.58% | - |
| Latin America, Middle East, Russia and Africa | 841M | 895M | 965M | - |
| Latin America, Middle East, Russia and Africa Growth | - | 6.42% | 7.82% | - |
Organon & Co. (OGN) has a price-to-earnings (P/E) ratio of 2.6x. This may indicate the stock is undervalued or faces growth challenges.
Organon & Co. (OGN) reported $6.30B in revenue for fiscal year 2024. This represents a 36% decrease from $9.78B in 2018.
Organon & Co. (OGN) grew revenue by 2.2% over the past year. Growth has been modest.
Yes, Organon & Co. (OGN) is profitable, generating $501.0M in net income for fiscal year 2024 (13.5% net margin).
Yes, Organon & Co. (OGN) pays a dividend with a yield of 13.17%. This makes it attractive for income-focused investors.
Organon & Co. (OGN) has a return on equity (ROE) of 429.9%. This is excellent, indicating efficient use of shareholder capital.
Organon & Co. (OGN) generated $566.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.